BiPER Therapeutics
Preclinical biotechnology company
BiPER Therapeutics has raised €1.3M across 1 funding round from 3 investors, most recently a Seed round in Feb 2023. Based in Strasbourg, France; active in Healthtech. Data as of 4 Nov 2026.
Strasbourg, Francebiper-tx.com ↗
Total raised
€1.3M
€1,250,000
Funding rounds
1
Investors
3
distinct backers
Active since
2023-02
latest 2023-02
Funding by year
EUR raised per yearBiPER Therapeutics — funding by year — interactive chart.
Data table
| BiPER Therapeutics — funding by year | |
|---|---|
| 2023 | €1.3M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-14 | Seed | €1.3M | Bpifrance,Grand Est region,WiSEED | View deal → |
Investors
3Related news
- BiPER Therapeutics Raises €1.25M in Seed Fundingfinsmes.com · 2023-02
Similar companies
same sector, similar sizeGlobal coverage: FundingData